Abstract
A physician tries a new bone active agent in his practice; his patients seem to improve and he is enthusiastic. Another, trying the same agent, sees little patient improvement, but notes serious drug side effects, and becomes convinced that the drug is more trouble than it is worth. Both are wrong, as the Hippocratic maxim suggests. It is impossible to say how much of the difference between the two experiences is due to placebo effects, to variations in the biological makeup of the patients concerned, or simply to random chance.
“... experience is misleading, and judgement is difficult. ” — Hippocrates
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Heaney RP. (1996) Design considerations for osteoporosis trials. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego pp. 1125–1142.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag London Limited
About this chapter
Cite this chapter
Heaney, R.P. (1998). How to Interpret New Data. In: Geusens, P. (eds) Osteoporosis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-3382-7_31
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3382-7_31
Publisher Name: Springer, London
Print ISBN: 978-3-540-76223-2
Online ISBN: 978-1-4471-3382-7
eBook Packages: Springer Book Archive